Clinical trial demonstrates the effectiveness of ALS drug in treating people with acute spinal cord injuries

A small clinical trial with a pharmacokinetic sub-study, led by a world-renowned pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury.

Blank check, please? Three healthcare SPACs reveal their IPO plans

SPACs might never fully go away if the ambitions of three new healthcare-focused shops have any sway. As initial public offerings are far and few

June 20, 2024

Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy

Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body’s own immune system to fight a tumor.

June 7, 2024

Resmed’s magnetized masks linked to 6 patient injuries, FDA says

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Interference between magnets in certain

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.